ARQUTE G.A.S.

ARQUTE G.A.S.

ICO Ended
14,302 Views
The studio unites the best specialists in the animation sphere. Among their
cases are products that bring investors an annual profit of millions of dollars - “Be-be-bears”, “Cartoon in Movie”, “The Fixies”, “Arkadiy Parovozov”, “The Pooches”, “Masha and the Bear”. “License royalties for the use of the brand and characters bring an additional income, which is 80% of the basic profit.”

Animation is a product of intellectual property. Rights holders get profit from any monetization of the product. ARQUTE G.A.S – studio based on blockchain technology, in which every token contains the copyright’s to
intellectual property. “Similar products in this industry bring investors from $ 2,000,000 per year.”
5.9
TOTAL SCORE
7.3
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 19 Mar 2018 - 01 June 2018
Country: Russia
Token info
Ticker: AGAS
Platform: Ethereum
Token Type: ERC20
Available for sale: 8,000,000 AGAS (80%)
Financial
Pre-sale Price : 1 AGAS = 0.001 ETH
ICO Price: 1.1400 USD
Accepting: ETH
Hard cap: 20,000 ETH
May, 2011
Foundation of the ARQUTE community.
September, 2017
Preparing a project to launch ICO<br /> <br /> .
March 19th, 2018
Launching of the Pre-ICO.<br /> <br /> Developing a platform for managing the Studio.<br />
April 16th, 2018
Starting the ICO.<br /> <br /> Launching the Preproduction of the first product.<br /> <br /> Beginning of the Studio management platform.
May 14th, 2018
Launching the Pro-ICO.<br /> <br /> Creating a Studio structure.<br /> <br /> Selecting the location of the head office.
June, 2018
Launching of the production of the first product.<br />
September, 2018
Launch of Post-production of the first product.<br /> <br /> Launching the Studio Management Platform.
November, 2018
Launch of the first Studio product.<br /> <br /> Beginning of marketing promotion of the product.
2019
The beginning of profit on the first product.<br /> <br /> The beginning of profit distribution between the olders of the tokens.<br /> <br /> Development and production of the following products.
Screenshots taken on 20 Mar 2018
Dennis Langley
Founder and CEO
No participating data
Alexey Kashpersky
Founder
No participating data
Arsen Uvaydov
Founder and CMO
No participating data
Daria Trofimova
Producer
No participating data
Valeria Michailova
Producer
No participating data
Kate Kuvshinova
Manager
No participating data
Julia Immortova
Manager
No participating data
Dmitry Vishnevsky
Art Director
No participating data
Kate Terekhovich
Advisor
No participating data
Andrey Shishkanov
Advisor
No participating data
Boris Mashkovcev
Advisor
No participating data
Anton Lanshakov
Advisor
No participating data
Maxim Revin
Advisor
No participating data
Alex Naumov
Head of IT
No participating data
Vasiliy Alekseev
Technical Director
No participating data
Michael Blank
Project Manager
No participating data
Alex Erenskiy
IT Specialist
No participating data
Sergey Ershov
Legal support
No participating data

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
TruePlay
TruePlay is a B2B platform with a complex of software solutions for online gambling business. TruePlay is not a gambling-provider, casino operator or casino owner. TruePlay allows only licensed gambling companies to access to their software (Software-as-a-service). The team are aimed at developing online gambling and making it as legal and transparent as possible from any point of view, TruePlay team has strong partners and has more than 10 years’ experience in the gambling industry.Join TruePlay and take part in the development of the gambling industry.
Upcoming
ReverseDAO
ReverseDAO is a solution to all of the problems above; it is a platform that connects the Metaverse with real-world assets. Fiat and economic units that are bound with world assets can now be represented, stored, and transferred onto the blockchain just as easily as cryptocurrencies.
Upcoming
DexBerry
DexBerry is a next-generation decentralized ecosystem Mega-Application backed by a revolutionary smart contract technology. The Mission of DexBerry is to leverage ever-evolving blockchain technologies to provide users with an application that supports easy access to cross-chain liquidity and tools for fast, easy, and secure acquisition of digital assets without moving from one project feature to another. With DexBerry, users can Analyze, Advertise, Acquire, Create, Compete, Earn, Game, Launch, Swap & more without moving 1 INCH.
Upcoming
Earth Token
The Natural Asset Exchange blockchain platform and Earth Token cryptocurrency initial coin offering (ICO) token sale provides a unique opportunity to truly transform the Natural Capital Asset market, by creating a Natural Asset Marketplace that allows all stakeholders in the climate value chain to participate.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.